Genetically engineered mesenchymal stromal cells as a new trend for treatment of severe acute graft-versus-host disease.

Autor: Keshavarz Shahbaz, Sanaz1 (AUTHOR), Mansourabadi, Amir Hossein2,3 (AUTHOR), Jafari, Davood4,5 (AUTHOR) d.jafari@zums.ac.ir
Zdroj: Clinical & Experimental Immunology. Apr2022, Vol. 208 Issue 1, p12-24. 13p.
Databáze: Academic Search Ultimate